Cognitive Ability, General
Conditions
Brief summary
This is a follow-up study of a multi-center, double-blind, randomized, controlled, parallel-designed, prospective trial and is intended to evaluate neurodevelopment at 5.5 years of age and health outcomes through 5.5 years of age in participants who received one of two staged study formulas through one year of age.
Interventions
DIETARY_SUPPLEMENTEnriched Protein Fractions
Enriched protein fractions
DIETARY_SUPPLEMENTProtein Fraction
Protein fractions
Sponsors
Mead Johnson Nutrition
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
64 Months to 68 Months
Healthy volunteers
Yes
Inclusion criteria
* Participant who previously consumed study formula through one year of age in MJN Project 6027 * 5.5 years of age (i.e. when child turns 5 years and 6 months old ± 2 months) at Visit 1 * Signed informed consent obtained for child's participation in the study
Exclusion criteria
* No
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wechsler Preschool & Primary Scale of Intelligence™ (Fourth Edition; WPPSI™-IV) | At 5.5 years of age |
Secondary
| Measure | Time frame |
|---|---|
| Stroop Task | At 5.5 years of age |
| Functional Near Infrared Spectroscopy (fNIRS) | At 5.5 years of age |
| Child Behavior Checklist (CBCL) | At 5.5 years of age |
| Dimensional Change Card Sort (DCCS) | At 5.5 years of age |
| Body height | At 5.5 year of age |
| Health history outcomes | At 5.5 years of age |
| Body weight | At 5.5 years of age |
Countries
China
Outcome results
None listed